BIOMARKERS MARKET ANALYSIS

Biomarkers Market, By Product Type (Biomarkers Test Kits, Biomarker Analyzer), By Application (Diagnostic Biomarkers, Monitoring Biomarkers, Drug discovery and development, Predictive biomarkers, Prognostic biomarkers), By Disease Indication (Cancer, Cardiovascular disorders, Neurological Disorder, Infectious Disease, Others (Immunological Disorder, and Autoimmune Disorders among others )), By End User (Hospitals, Research laboratories, Diagnostic laboratories, Research and academic institute), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030

Published In : Jan 2023
Code : CMI1530
Pages :187
Formats :
Excel and PDF
Industry : Biotechnology

Regional Analysis

Global Biomarkers Market – Regional Analysis

On the basis of region, the global biomarkers market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa.

Among regions, North America is expected to hold a dominant position in the global biomarkers market during the forecast period owing to increasing product designations by regulatory authorities. For instance, on September 1, 2022, U.S. FDA granted a breakthrough device designation to Roche’s Elecsys Amyloid Plasma panel, which is a blood based Alzheimer’s test. This panel helps healthcare professionals to detect Alzheimer’s at an early stage.

North America: U.S. and Canada
Latin America: Brazil, Argentina, Mexico, and Rest of Latin America
Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe
Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific
Middle East: GCC, Israel, and Rest of Middle East
Africa: South Africa, North Africa, and Central Africa